{"id":188071,"date":"2024-04-24T22:32:12","date_gmt":"2024-04-25T03:32:12","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2024\/04\/xaira-launches-with-1bn-for-ai-drug-discovery-and-development"},"modified":"2024-04-24T22:32:12","modified_gmt":"2024-04-25T03:32:12","slug":"xaira-launches-with-1bn-for-ai-drug-discovery-and-development","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2024\/04\/xaira-launches-with-1bn-for-ai-drug-discovery-and-development","title":{"rendered":"Xaira launches with $1bn for AI drug discovery and development"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/xaira-launches-with-1bn-for-ai-drug-discovery-and-development2.jpg\"><\/a><\/p>\n<p>Xaira has recruited a group of researchers who developed the leading models for protein and antibody design while in Baker\u2019s lab. The company aims advance these models and develop new methods that can \u201cconnect the world of biological targets and engineered molecules to the human experience of disease.\u201d<\/p>\n<p>\u201cDriven by growing data sets and new methods, there has been accelerating progress in artificial intelligence and its applications to medicine, biology and chemistry, including seminal work from David Baker\u2019s lab at the Institute for Protein Design,\u201d said Foresight\u2019s Dr Vikram Bajaj. \u201cIn starting Xaira, we have brought together incredible multidisciplinary talent and capabilities at the right time to reimagine our entire approach, from drug discovery to clinical development.\u201d<\/p>\n<p>Boasting proficiency in handling vast and multidimensional datasets, Xaira claims it will enable comprehensive characterization of disease biology at various levels, from molecular to clinical. Drawing from Illumina\u2019s functional genomics R&amp;D effort and integrating a key proteomics group from Interline Therapeutics, the company aims to gain new insights into disease mechanisms.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Xaira has recruited a group of researchers who developed the leading models for protein and antibody design while in Baker\u2019s lab. The company aims advance these models and develop new methods that can \u201cconnect the world of biological targets and engineered molecules to the human experience of disease.\u201d \u201cDriven by growing data sets and new [\u2026]<\/p>\n","protected":false},"author":359,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,19,6],"tags":[],"class_list":["post-188071","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-chemistry","category-robotics-ai"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/188071","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/359"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=188071"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/188071\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=188071"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=188071"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=188071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}